EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Development of CDC25A-Derived Phosphoseryl Peptides That Bind 14-3-3ε with High Affinities

Seraphine Kamayirese, Sibaprasad Maity, Laura A Hansen, Sándor Lovas iD

International Journal of Molecular Sciences · 30.04.2024 · 25 (9) · 4918

DOI: 10.3390/ijms25094918 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 30.04.2024. Verfasst von Seraphine Kamayirese und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, Creighton University, Omaha, NE 68178, USA. Hauptthemen laut MEDLINE: cdc25 Phosphatases, 14-3-3 Proteins, Protein Binding, Molecular Dynamics Simulation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Overexpression of the 14-3-3ε protein is associated with suppression of apoptosis in cutaneous squamous cell carcinoma (cSCC). This antiapoptotic activity of 14-3-3ε is dependent on its binding to CDC25A; thus, inhibiting 14-3-3ε – CDC25A interaction is an attractive therapeutic approach to promote apoptosis in cSCC. In this regard, designing peptide inhibitors of 14-3-3ε – CDC25A interactions is of great interest. This work reports the rational design of peptide analogs of pS, a CDC25A-derived peptide that has been shown to inhibit 14-3-3ε–CDC25A interaction and promote apoptosis in cSCC with micromolar IC50. We designed new peptide analogs in silico by shortening the parent pS peptide from 14 to 9 amino acid residues; then, based on binding motifs of 14-3-3 proteins, we introduced modifications in the pS(174–182) peptide. We studied the binding of the peptides using conventional molecular dynamics (MD) and steered MD simulations, as well as biophysical methods. Our results showed that shortening the pS peptide from 14 to 9 amino acids reduced the affinity of the peptide. However, substituting Gln176 with either Phe or Tyr amino acids rescued the binding of the peptide. The optimized peptides obtained in this work can be candidates for inhibition of 14-3-3ε – CDC25A interactions in cSCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

cdc25 Phosphatases14-3-3 ProteinsProtein BindingMolecular Dynamics SimulationHumansPeptidesAmino Acid Sequence

Stichwörter der Autor:innen

14-3-3biophysical methodscutaneous squamous cell carcinomainhibitorsmolecular dynamics simulationsphosphopeptides

Substanzen

cdc25 Phosphatases14-3-3 ProteinsPeptidesCDC25A protein, human

Autor:innen und Institutionen

  • Department of Biomedical Sciences, Creighton University, Omaha, NE 68178, USA.

ORCID-Profile: Sándor Lovas

Förderung

  • NCI NIH HHS
  • NIH HHS
  • National Institutes of Health
  • State of Nebraska

Zitieren

APA

Kamayirese, S., Maity, S., Hansen, L. A., & Lovas, S. (2024). The Development of CDC25A-Derived Phosphoseryl Peptides That Bind 14-3-3ε with High Affinities. International Journal of Molecular Sciences, 25(9), 4918. https://doi.org/10.3390/ijms25094918

Vancouver

Kamayirese S, Maity S, Hansen LA, Lovas S. The Development of CDC25A-Derived Phosphoseryl Peptides That Bind 14-3-3ε with High Affinities. International Journal of Molecular Sciences. 2024;25(9):4918. doi:10.3390/ijms25094918

BibTeX
@article{Kamayirese2024,
  author = {Kamayirese, Seraphine and Maity, Sibaprasad and Hansen, Laura A and Lovas, Sándor},
  title = {The Development of CDC25A-Derived Phosphoseryl Peptides That Bind 14-3-3ε with High Affinities},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {9},
  pages = {4918},
  doi = {10.3390/ijms25094918}
}
Kostenlos starten →